PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12009331-5	2002	U0126 conferred 37-77% (MMP-3) and 43-73% (MMP-13) suppression in human and 77-100% (MMP-3) and 96-100% (MMP-13) in bovine chondrocytes.	U 0126	0-5	matrix metallopeptidase 13	Homo sapiens	43-49	
12009331-5	2002	U0126 conferred 37-77% (MMP-3) and 43-73% (MMP-13) suppression in human and 77-100% (MMP-3) and 96-100% (MMP-13) in bovine chondrocytes.	U 0126	0-5	matrix metallopeptidase 13	Homo sapiens	105-111	
14755151-9	2004	Mitogen-activated protein (MAP) kinase inhibitors (U0126 and PD098059) also blocked the MMP-1, -3 and TIMP-1 secretion.	U 0126	51-56	matrix metallopeptidase 13	Homo sapiens	88-97	
14516792-7	2003	Gene and protein expression of other MMPs that regulate MMP-9, such as MMP-1 and MMP-13, were also up-regulated by TNF-alpha and inhibited by UO126, providing evidence that the MAPK pathway plays a fundamental role in the regulation of MMP-9 secretion by keratinocytes.	U 0126	142-147	matrix metallopeptidase 13	Homo sapiens	81-87	
19542681-4	2009	An ERK-MAPK pathway inhibitor (U0126), but not a p38 kinase inhibitor (SB203580) or a JNK inhibitor (SP600125), also selectively inhibited IL-1beta-induced MMP-13 production in HAC.	U 0126	31-36	matrix metallopeptidase 13	Homo sapiens	156-162	
18487224-8	2008	Again, U0126 almost inhibited the induction of MMP-13 in HEp-2 cells by stimulating CXCL12.	U 0126	7-12	matrix metallopeptidase 13	Homo sapiens	47-53	
17208315-4	2007	Extracellular signal-regulated kinases (ERK1/2)-MAPK pathway inhibitor, U0126, down-regulated ADAMTS-4 and MMP-13 induction by OSM.	U 0126	72-77	matrix metallopeptidase 13	Homo sapiens	107-113